Patent ID: 7750047

Claim:
A method of inhibiting histone acetyltransferases in a patient requiring same, the method comprising administering to the patient an amount of a compound of formula (II): wherein R 11 is selected from the group consisting of hydrogen, linear or branched C 8-18 alkyl, and linear or branched C 8-18 alkenyl; R 12 is selected from the group consisting of hydrogen and wherein R 12′ is selected from the group consisting of hydrogen, hydroxy, halogen, linear or branched C 1-6 alkyl, and linear or branched C 1-6 alkoxy R 13 is selected from the group consisting of hydrogen, methyl, hydroxyl, carboxylic, O-methoxy, O-ethoxy, n-propoxy, O-isopropoxy, n-butoxy, t-butoxy, C 8 H 18 , C 15 H 26 , C 15 H 28 , C 15 H 30 , and C 15 H 32 ; R 14 is hydrogen; R 15 is selected from the group consisting of hydrogen and hydroxyl and R 16 is hydrogen; provided that R 11 and R 12 are not simultaneously hydrogen; or a pharmaceutically suitable salt thereof, wherein the amount is sufficient to inhibit histone acetyltransferases in the patient.